SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-13-001162
Filing Date
2013-11-08
Accepted
2013-11-08 17:27:18
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20131001.htm 10-Q 1618238
2 EXHIBIT 31.1 dvax-ex31_2013093011.htm EX-31 37538
3 EXHIBIT 31.2 dvax-ex31_2013093042.htm EX-31 36393
4 EXHIBIT 32.1 dvax-ex32_2013093013.htm EX-32 10254
5 EXHIBIT 32.2 dvax-ex32_2013093014.htm EX-32 10150
  Complete submission text file 0001564590-13-001162.txt   8152201

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20130930.xml EX-101.INS 1454742
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20130930.xsd EX-101.SCH 38685
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20130930_cal.xml EX-101.CAL 43783
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20130930_def.xml EX-101.DEF 251323
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20130930_lab.xml EX-101.LAB 340223
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20130930_pre.xml EX-101.PRE 290092
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 131205875
SIC: 2834 Pharmaceutical Preparations